+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 6Years - 11Years
All Genders
ID06804811

Phase 3 Study of Ruxolitinib Cream Versus Placebo in Children Ages 6 to Under 12 With Nonsegmental Vitiligo

Led by Incyte Corporation · Updated on 2026-10-09

250

Participants Needed

78

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the effectiveness and safety of ruxolitinib cream in children aged 6 to under 12 years old who have nonsegmental vitiligo. This phase 3 study aims to understand how well ruxolitinib cream works to improve skin depigmentation in this young population. The study compares two strengths of ruxolitinib cream against a placebo cream, with participants randomly assigned to one of the groups. Participants apply either 0.75% or 1.5% ruxolitinib cream, or a matching placebo cream, as a thin layer on the affected skin areas twice daily. The treatment lasts for 24 weeks, with the primary goal of measuring improvement in facial vitiligo area. The study also monitors other outcomes such as body vitiligo improvement, patient satisfaction, and possible side effects for up to 52 weeks. During the study, participants will be regularly assessed for changes in their vitiligo using standardized scoring indexes and questionnaires that measure the impact on quality of life. Blood samples will be taken at several points to study the drugs levels in the body. Safety is closely monitored, and participants are followed through a final safety visit. Overall participation can last up to around one year, including treatment and follow-up periods.

CONDITIONS

Brief Title

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

Research Team

I

Incyte Corporation Call Center (US)

I

Incyte Corporation Call Center (ex-US)

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here